May 10 Stemline Therapeutics Inc:
* Stemline therapeutics reports first quarter 2017 financial results
* Q1 loss per share $0.67
* Q1 earnings per share view $-0.47 -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:
UPDATE 1-Property markets outlook remains strong as golden age fades -PGIM
NEW YORK, June 27 A golden period in global property markets appears near an end as rising interest rates and lower returns hurt performance, but the outlook for real estate remains strong, asset manager PGIM said on Tuesday.